"10.1371_journal.pone.0026690","plos one","2011-10-31T00:00:00Z","Jordi Ferrer; Clara Prats; Daniel López; Jaume Vidal-Mas; Domingo Gargallo-Viola; Antonio Guglietta; Antoni Giró","Departament de Física i Enginyeria Nuclear, Escola Superior dAgricultura de Barcelona, Universitat Politècnica de Catalunya, Castelldefels, Spain; Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain; Pharmacology and Safety Department, Ferrer Grupo Research Center, Barcelona, Spain","Conceived and designed the experiments: DL DGV AGuglieta AGiró. Performed the experiments: JF JVM. Analyzed the data: JF CP DL. Contributed reagents/materials/analysis tools: JVM DGV. Wrote the paper: JF CP. Defined the framework of the collaboration and of the research project: DGV DL AGiro AGuglieta. Supervised the results: DGV DL AGiro AGuglieta. Approved manuscript publication: DGV DL AGiro AGuglieta.","I have read the journals policy and have the following conflicts: JVM is an employee of GlaxoSmithKline. DGV is a former employee of GlaxoSmithKline and current employee of FerrerGrupo. AGuglietta is an employee of FerrerGrupo. The research group received funding from a commercial source (Ipsen Pharma). These competing interests do not alter our adherence to all the PLoS ONE policies on sharing data and materials.","2011","10","Jordi Ferrer","JF",7,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
